ArticleBMC bioinformatics2025
Bayesian compositional generalized linear mixed models for disease prediction using microbiome data.
Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- BCGLMs: Bayesian modeling for disease prediction using compositional microbiome features.Bioinformatics advances · 2026Article
- Sex differences in the association of physical activity patterns with all-cause and cardiovascular mortality: a prospective cohort study from NHANES 2007-2018.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The primary goal of predictive modeling for compositional microbiome data is to better understand and predict disease susceptibility based on the relative abundance of microbial species. Current approaches in this area often assume a high-dimensional sparse setting, where only a small subset of microbiome features is considered relevant to the outcome. However, in real-world data, both large and small effects frequently coexist, and acknowledging the contribution of smaller effects can significantly enhance predictive performance. To address this challenge, we developed Bayesian Compositional Generalized Linear Mixed Models for Analyzing Microbiome Data (BCGLMM). BCGLMM is capable of identifying both moderate taxa effects and the cumulative impact of numerous minor taxa, which are often overlooked in conventional models. With a sparsity-inducing prior, the structured regularized horseshoe prior, BCGLMM effectively collaborates phylogenetically related moderate effects. The random effect term efficiently captures sample-related minor effects by incorporating sample similarities within its variance-covariance matrix. We fitted the proposed models using Markov Chain Monte Carlo (MCMC) algorithms with rstan. The performance of the proposed method was evaluated through extensive simulation studies, demonstrating its superiority with higher prediction accuracy compared to existing methods. We then applied the proposed method on American Gut Data to predict inflammatory bowel disease (IBD). To ensure reproducibility, the code and data used in this paper are available at https://github.com/Li-Zhang28/BCGLMM .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.